Warning: Attempt to read property "post_parent" on null in /home2/diverto2/public_html/santiagotimes/wp-includes/link-template.php on line 479
Warning: Attempt to read property "post_name" on null in /home2/diverto2/public_html/santiagotimes/wp-includes/link-template.php on line 517
Warning: Attempt to read property "ID" on null in /home2/diverto2/public_html/santiagotimes/wp-includes/link-template.php on line 534
Warning: Attempt to read property "post_excerpt" on null in /home2/diverto2/public_html/santiagotimes/wp-content/themes/mh-magazine/includes/mh-custom-functions.php on line 392 Warning: Trying to access array offset on value of type bool in /home2/diverto2/public_html/santiagotimes/wp-content/themes/mh-magazine/includes/mh-custom-functions.php on line 394
Warning: Attempt to read property "post_title" on null in /home2/diverto2/public_html/santiagotimes/wp-content/themes/mh-magazine/includes/mh-custom-functions.php on line 394
Chilean authorities gave approval to Elanco for its Imvixa drug that is given to Atlantic salmon and trout to fight caligus in fish, the company said.
Imvixa is administered to fish orally during their freshwater phase and has been shown to reduce chitin in caligus that stops them from becoming adults, the company said in a statement.
“The control of the parasite generates constant pressure for salmon producers, it is time consuming, complicated and stressful for the fish and as much for the aquaculture companies,” Carlos Kuada, Elanco’s global director for the aquaculture business. “Elanco is proud to take this treatment to production centers responding to a big need for the Chilean salmon industry.”
Caligus costs the salmon industry $1 billion in extra costs annually, and Chile also suffers from the presence of caligus rogercresseyi, a strand of the parasite.
Fish treated with Imvixa in lab tests were within the regulatory limits for parasites on fish, comparing favourably to untreated fish, the company said. Another company, Tecnovax, launched a sea lice vaccine in Chile last year.
Elanco has been operating since 1953 and has a presence in more than 70 countries, according to the company’s website. (undercurrent News)
611875 217148Some truly nice stuff on this site, I enjoy it. 222719
735253 556017I think this web site contains some extremely excellent information for every person : D. 313038
25245 14896Thanks for helping out, excellent info. 769589